Showing 1-5 of 84 big data:
OM1 Contributes to Alzheimer’s Disease Research With New PremiOM Dataset of Over 1 Million Patients

Read the full press release >> July 30, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leader in real-world insights synthesis and evidence generation for life sciences supporting population and personalized data insights, evidence generation through advanced validated AI platforms, big deep clinical data, registries, and globally recognized thought leadership today announced the new[…]

Unveiling the Unseen: AI’s Role in Identifying Treatment-Resistant Depression

Thu, Aug 15, 2024 2:00 PM – 3:00 PM EDT Presenter: Carl Marci, MD, Chief Clinical Officer and Chief Psychiatrist and Managing Director of Mental Health and Neuroscience, OM1 Register >> Treatment-resistant depression (TRD) presents a formidable challenge for life sciences researchers, with its complex definition varying across clinical care, reimbursement, and regulatory contexts. This[…]

Digital Health & AI Innovation Summit

Event: Digital Health & AI Innovation Summit When: October 7-9, 2024 Where: Cambridge, MA Booth #: 5 OM1 Presentation: Joseph Zabinski, VP Commercial Strategy & AI, OM1  Monday October 7th at 9:40 am For additional information or to schedule a meeting with our experts, contact us at info@om1.com

2024 ISPE Annual Meeting

2024 ISPE Annual Meeting When: August 24-28, 2024 Where: Berlin, Germany Booth: 303 OM1 will be at ICPE in Berlin! Find our team of experts at booth #303, or book a meeting with us to learn how our clinical expertise and integrated evidence approach brings together real-world data, AI, and automated, regulatory-enabled platforms to help[…]

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

June 24, 2024 Pharma’s Almanac Read the full article >> Rich Gliklich, M.D., Chief Executive Officer and founder, OM1 One impactful way will be through platforms that enable data and study automation. In recent remarks, FDA Commissioner Dr. Robert Califf argued that there is tremendous opportunity to simplify and digitize data collection to create more pragmatic[…]

1 2 3 17